Publications by authors named "S V Kopishinskaia"
Article Synopsis
- Several neurological issues can persist in patients who have recovered from COVID-19, and this study focused on their outcomes at the 6-month mark.
- The research involved over 1,000 patients and found that approximately 52% showed stable or improved functional status, while 46% experienced worse outcomes, with factors like age and hospitalizations influencing these results.
- Among the neurological symptoms that persisted, fatigue and memory or concentration problems were the most common, highlighting the need for awareness of long-term effects in COVID-19 survivors.
Somatic multicomorbidity and disability in patients with psychiatric disorders in comparison to the general population: a quasi-epidemiological investigation in 54,826 subjects from 40 countries (COMET-G study).
CNS Spectr
April 2024
Background: The prevalence of medical illnesses is high among patients with psychiatric disorders. The current study aimed to investigate multi-comorbidity in patients with psychiatric disorders in comparison to the general population. Secondary aims were to investigate factors associated with metabolic syndrome and treatment appropriateness of mental disorders.
View Article and Find Full Text PDFBackground: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a severe, debilitating chronic disease characterized by marked tiredness and fatigue, cognitive dysfunction, sleep disturbances, pain, and autonomic, immunological, and metabolic dysfunctions, in which all symptoms are usually exacerbated by physical and/or psychological stress.
Subjects And Methods: We report a case of ME/CFS with severe myalgia and severe locomotor disorders in a 25-year-old female after Gam-COVID-Vac vaccine (Sputnik V) ten days before the manifestation of the symptoms.
Results: This is the first report of such a complication from the Gam-COVID-Vac vaccine.